INKA2 and hepatocellular carcinoma: The findings revealed that HCC patients with high INKA2-AS1 expression had shorter OS (Figure 5(a), P = 0.001), DSS (Figure 5(b), P = 0.036), and PFI (Figure 5(c), P = 0.024) than those with low INKA2-AS1 expression.